Navigation Links
Former U.S. Assistant Surgeon General, Dr. Susan Blumenthal, to Lead Meridian International Center's Global Health Program
Date:8/21/2008

WASHINGTON, Aug. 21 /PRNewswire-USNewswire/ -- Meridian International Center today announced that its board member, former U.S. Assistant Surgeon General Susan Blumenthal, M.D. will lead Meridian's new Global Health Program. The Global Health Program is now a key initiative of Meridian's programs that include world affairs public briefings and conferences, U.S. State Department International Visitor Leadership Programs, and arts and cultural activities.

"Today, 79% of people suffering from chronic diseases are found in the developing world, and 1,100 epidemics have been reported by the World Health Organization in the last five years alone. These problems have humanitarian, economic and national security implications that impact all nations. The new Meridian Global Health Program will provide an important forum to address these issues," said Dr. Blumenthal.

Health will also be included as a critical track in Meridian's Global Engagement Initiative that brings together leading experts, innovators, and thought leaders around five major worldwide issues: cultural understanding; entrepreneurship and economic development; energy and the environment; new media and technology; and global health. Meridian's Global Engagement Initiative builds on its 50-year history of facilitating international exchange and cooperation on key issues.

"Meridian brings together the brightest leaders from around the world to foster the international cooperation necessary to help develop lasting solutions to global problems," said Ambassador Stuart W. Holliday, President of Meridian International Center. "The Global Engagement Initiative was created to tune into public opinion, listen to the priorities of world citizens, and to strengthen global collaboration on problems that transcend national boundaries and require international cooperation to achieve a common solution."

Rear Admiral Susan J. Blumenthal, M.D., M.P.A. served as U.S. Assistant Surgeon General,
'/>"/>

SOURCE Meridian International Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
2. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Former State Representative Terry Parke Joins Secure Services Corp.
5. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
6. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, & Countrys Top Drug Treatment CEO Barry Karlin to Keynote Palm Beach, FL National Moment Of Change Intervention Conference:
7. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
8. Former HHS Secretary Dr. Louis Sullivan, Lt. Gov. Cagle Address Need to Improve Quality of Patient Care
9. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
10. Nobel Honors 3 Former March of Dimes Prize Recipients
11. Over one-third of former American football players had sexual relations with men, study says

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... heavy can lead to strains or worse , , ... nothing wrong with stuffing your turkey full to b...ng with your suitcase as you pack for holiday trip...08 in U.S. hospital emergency rooms, doctors, offi...age-related injuries, such as muscle strains, pull...
(Date:11/26/2009)...earch Triangle Dental (RTDental), a leading dental...nnounced the expansion of its services to include ...g Macmillan. , Durham,... to announce that Dr. Doug Macmillan, an experienc...tional advanced training seminar. RTDental’...
(Date:11/25/2009).../PRNewswire/--TheBartleHallConventionCenterwilltem....9-10,whenKansasCityhoststhelatestinaseriesofmassi...iniceventhasthepotentialtobethebiggestoneyet,becau...onweekdaysinsteadofoveraweekend,"SheriWood,executi...entoftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...25/PRNewswire/--Thanksgivingmealswillbedeliveredto...BeachareathankstoFaithInAction/VolunteerActionforA...visionofSCANHealthPlan.Formorethan17yearstheseorga...warmThanksgivingmealstoseniorsinneedinLongBeach,La...undingcities. ,, "Ourwarmholidaymealsaredeliver...
(Date:11/25/2009)...ements,Business,andPressJoinEfforttoEducate ,,...again,theNationalBipolarFoundationandtheMedicAlert...tilStable"program,whichisnowbeingwidelyacceptedasa...y,theNationalBipolarFoundationreceivedaproclamatio...Lt.GovernorofLouisianaMitchLandrieu.TheNationalBip...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3
..., May 7 Conseco, Inc. (NYSE: CNO ),today reporte...t a new quarterly sales record with an increase of...ieur said. "This performance included,an 11% incre...surance Group,s sales declined 21%, but specified ...
...is common in the aggressive form of the disease, r...althDay News) -- For the first time, a gene linked... has been identified, researchers report. , "This ...ldhood Cancer Research at The Children,s Hospital ...
...ON, May 7 -- Shire plc(LSE: SHP, Nasdaq: SHPGY), ...esented today at a major scientific meeting findin...NIV, a selective alpha-2A-agonist. This compound,...(ADHD)., The data demonstrated that INTUNIV showed...
...ct Examination Finds Serious Violations in Long-Te... Acting Insurance,Commissioner Joel Ario today ann...ich was necessary due to a pattern of consumer har...2.3 million fine and an additional $30,million in ...
....3 million fine, CARMEL, Ind., May 7 Conseco, In...g state insurance regulators and two of,its insura...(CSHI) Company,and Bankers Life and Casualty Compa...e claims practices and,procedures, complaint handl...
...y 7 Longer life expectancy, greater,interest in s...ccess are,all factors fueling growth in sales of o...ted $68.4 billion in 2007 sales, with a 3.9% CAGR ... BTC and Other Growth Trends, this market should e...
Other Medicine News:Health News:Conseco Reports First Quarter Results 2Health News:Conseco Reports First Quarter Results 3Health News:Conseco Reports First Quarter Results 4Health News:Conseco Reports First Quarter Results 5Health News:Conseco Reports First Quarter Results 6Health News:Conseco Reports First Quarter Results 7Health News:Conseco Reports First Quarter Results 8Health News:Conseco Reports First Quarter Results 9Health News:Conseco Reports First Quarter Results 10Health News:Conseco Reports First Quarter Results 11Health News:Conseco Reports First Quarter Results 12Health News:Conseco Reports First Quarter Results 13Health News:Conseco Reports First Quarter Results 14Health News:Conseco Reports First Quarter Results 15Health News:Conseco Reports First Quarter Results 16Health News:Gene Variation Linked to Neuroblastoma, a Childhood Cancer 2Health News:Gene Variation Linked to Neuroblastoma, a Childhood Cancer 3Health News:Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms 2Health News:Insurance Department Fines Conseco Under Pennsylvania-Led, Multi-State Agreement 2Health News:Insurance Department Fines Conseco Under Pennsylvania-Led, Multi-State Agreement 3Health News:Conseco Reaches Settlement of Multistate Market Conduct Examination 2Health News:Self-Medication One of Many Factors Driving OTC Drug Market Past $80 Billion by 2012 2
(Date:11/25/2009)...rstCall/--FormanyofthemillionsofhearingimpairedAme...earingloss ,theholidaysmaynotbeallthathappy,saysau...identofHearUSA(Amex: EAR ),oneofAmerica,slargesthe...linkedhearinglosstostress,frustration,andsocialiso...ingswithfamiliesandfriends,whenmanyofthosewithhear...
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...sMarketAnalysisandForecaststo2015 ,, http://w...Devices-Market-Analysis-and-Forecasts-to-2015.html...Forecaststo2015 ,, Summary ,, Thisreportis...tingtotheUSdentaldevicesmarket.Italsooffersdetaile...
(Date:11/25/2009)...NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecompany...urgicaltreatmentsforthespine,announcedtodaythatitw...:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocusonc...productsandwillincludecommentsfrommanagementfollow...rsare1-877-407-4018fordomesticcallersand1-201-689-...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Einstein to develop anti HIV drug delivery system 10245 1Einstein to develop anti HIV drug delivery system 10245 2Einstein to develop anti HIV drug delivery system 10245 3Thirty one Minnesota Hospitals Win Patient Safety Awards 58783 1Thirty one Minnesota Hospitals Win Patient Safety Awards 58783 2Pillar Capital Announces Acquisition of Medico Labs Assets 58778 1Pillar Capital Announces Acquisition of Medico Labs Assets 58778 2
...ed at ICAAC -, BRIDGEWATER, N.J., Oct. 26 Ninety...randomized, open-label, ongoing clinical,trial sho...ted adults,taking PREZISTA(R) 800 mg (two 400 mg t...ed an undetectable viral load (<50 copies/mL) ...king lopinavir/ritonavir 800 mg/200,mg once daily ...
...ed physical function in patients,treated with ACTE...a two-year,Phase III study demonstrated that ACTEM...ogression of structural joint damage in patients w...ts from the LITHE study will,be featured as an ora...matology (ACR) Annual Scientific Meeting (October ...
Other Medicine Technology:Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 2Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 3Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 4Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 5Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 6Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 7Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 8New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients 5New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients 6
Tipack (Sterilized) DL10
Tipack (Sterilized) D10
10 L Pipette Tip (RNase, DNase and pyrogen free)
ART 300 Multi-Channel
Medicine Products: